Regulation of the second-messenger systems in the rat spinal cord during prolonged peripheral inflammation
- 1 July 1994
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 58 (1) , 63-75
- https://doi.org/10.1016/0304-3959(94)90185-6
Abstract
Unilateral intraplantar injection of Freund's complete adjuvant (FCA) into 1 hind paw of rats was used as a model of peripheral inflammation and persistent pain in order to examine time course effects of a continuous barrage of nociceptive input on the second-messenger transducing systems in the spinal cord. cAMP, cGMP and inositol 1,4,5-trisphosphate (insP3) were extracted from the lumbosacral cord at days 1, 7, 14, 21 and 42 following FCA injection and quantified by either radioreceptor-assay (RRA) or radioimmunoassay (RIA). The lumbosacral contents of cAMP and cGMP when quantified in whole lumbosacral cord segment were not significantly changed by FCA treatment at all time points. InsP3 accumulation was significantly increased on days 14, 21 and 42 following FCA injection relative to sham-treated time-matched controls. However, cGMP and insP3 contents were significantly increased in the left longitudinal half of the lumbar enlargement ipsilateral to the injected paw on day 21 following FCA treatment, but not in the sham-treated time-matched controls. With [3H]insP3 as a ligand, Scatchard (Rosenthal) analyses of the concentration-dependent saturation curves showed that the densities (Bmax) of insP3 receptors (insP3R) were significantly increased throughout the time course of adjuvant-induced peripheral inflammation. The binding affinities (KD) for insP3R were significantly decreased on days 7, 14 and 21 following FCA injection corresponding to the times of most stable and peak inflammation. InsP3R from the cerebelli of the same rats as used in the lumbosacral insP3R characterization was used as a positive control in this study and did not show any change in both Bmax and KD as a result of FCA treatment, thus demonstrating that the changes in lumbosacral insP3R characteristics might be specific to the nociceptive sensory pathway such as the spinal cord. Thus it appears that sustained afferent nociceptive input induced by FCA injection increased the accumulation of cGMP, insP3 and insP3R density in the spinal cord through increased neuronal activities of functional receptors coupled to major classes of chemical mediators of nociception including neuropeptides and excitatory aminoacids. Changes in insP3 accumulation in the lumbosacral cord following FCA injection were significantly correlated with changes in insP3R density. Changes in the ratios of lumbosacral insP3 contents and insP3R density were also significantly correlated with changes in body weight and hind paw size induced by FCA injection.(ABSTRACT TRUNCATED AT 400 WORDS)Keywords
This publication has 69 references indexed in Scilit:
- Neural changes in acute arthritis in monkeys. II. Increased glutamate immunoreactivity in the medial articular nerveBrain Research Reviews, 1992
- A simple, sensitive, and specific radioreceptor assay for inositol 1,4,5-trisphosphate in biological tissuesBiochemical and Biophysical Research Communications, 1989
- Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptideNeuroscience Letters, 1988
- Release of substance P from the spinal dorsal horn is enhanced in polyarthritic ratsNeuroscience Letters, 1987
- Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the ratNeuroscience Letters, 1984
- A practical computer-based approach to the analysis of radioligand binding experimentsComputer Programs in Biomedicine, 1983
- Time course of the ventilatory response to adjuvant arthritis in the ratLife Sciences, 1983
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983
- Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritisLife Sciences, 1983
- The depression-pain syndrome and its response to antidepressantsPsychosomatics, 1981